Anthera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

ANTH 3.09 +0.01 (0.32%)
price chart
How Many Anthera Pharmaceuticals Inc (NASDAQ:ANTH)'s Analysts Are Bullish?
Out of 3 analysts covering Anthera Pharmaceuticals (NASDAQ:ANTH), 3 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive.
Anthera Pharmaceuticals Inc (NASDAQ:ANTH) Realized Volatility Hits An Elevated ...
This is a proprietary realized volatility rating created by Capital Market Laboratories (CMLviz) based on a large number of data interactions for Anthera Pharmaceuticals Inc (NASDAQ:ANTH) . We examine the little used gem of daily stock volatilty over a ...
Earnings Focus and Crowd Sourced Sentiment Review for Anthera Pharmaceuticals ...
Street analysts and crowd investors have recently weighed in on shares of Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH).
Anthera Pharmaceuticals, Inc. (ANTH) Current Analyst Ratings
02/19/2016 - Anthera Pharmaceuticals, Inc. had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 9 price target on the stock.
Anthera Pharmaceuticals, Inc. Stock Momentum at Critical Inflection Point
This is a momentum stock rating analysis for Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) . The company has a three bull momentum rating which indicates an inflection point.
Anthera Pharmaceuticals Inc. Expected to Post FY2016 Earnings of ($1.19) Per ...
Anthera Pharmaceuticals logo Anthera Pharmaceuticals Inc. (NASDAQ:ANTH) - Investment analysts at SunTrust Banks cut their FY2016 EPS estimates for Anthera Pharmaceuticals in a report issued on Wednesday.
Company Update (NASDAQ:ANTH): Anthera Pharmaceuticals Inc Provides Clinical ...
Anthera Pharmaceuticals Inc (NASDAQ:ANTH) announced results from interim analysis of the Phase 2 BRIGHT-SC proof-of-concept study in 57 patients with biopsy-proven IgA Nephropathy.
Recently Issued Stock Ratings For Anthera Pharmaceuticals, Inc. (ANTH)  Fiscal Standard
Anthera Pharmaceuticals, Inc. (NasdaqGM:ANTH) Stock Momentum Hits Weakness
This is a momentum stock rating analysis for Anthera Pharmaceuticals, Inc. (NasdaqGM:ANTH) . The company has a two bull momentum rating which indicates some weakness.
Anthera Pharmaceuticals Inc (ANTH) Rating Reiterated by Jefferies Group
Anthera Pharmaceuticals Inc (NASDAQ:ANTH)'s stock had its “buy” rating reissued by research analysts at Jefferies Group in a research report issued to clients and investors on Thursday.
Anthera Pharmaceuticals, Inc. (ANTH) Updated Price Targets  FTSE News
Why Anthera Pharmaceuticals, Inc. Shares Are Soaring Higher
What: Shares in Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) jumped by 10% earlier today after the company announced after the bell yesterday that it would present updated data from its phase 2b study evaluating blisibimod as a treatment for lupus at an ...